Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0000950170-25-100365

President, R&D sold 30,770 shares at an average $3.69 ($113,478)

From the SEC's structured data for this filing

Trades in this filing

Bergstrom Donald A · President, R&D

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-07-28 Sale : show line 1 in the form −4,069 $3.74 $15,218 579,421 D
2025-07-29 Sale : show line 2 in the form −26,701 $3.68 $98,260 552,720 D
Open-market sales · 30,770 sh · avg $3.69 · $113,478
Loading xslF345X05/ownership.xml…